Outlook Therapeutics, Inc. Debt Instrument, Fair Value Disclosure
Financial Statements › Balance Sheet › Liabilities › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-02-17
- 2025-12-31: Debt Instrument, Fair Value Disclosure $32.23M.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $31.45M.
- 2025-06-30: Debt Instrument, Fair Value Disclosure $35.72M.
- 2025-03-31: Debt Instrument, Fair Value Disclosure $35.76M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2025-12-31 | $32.23M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $31.45M 10-K · filed 2025-12-19 |
| 2025-06-30 | $35.72M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $35.76M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $32.23M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $31.35M 10-K · filed 2024-12-27 |
| 2023-12-31 | $37.67M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $36.76M 10-K · filed 2023-12-22 |